Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06712901 · ClinicalTrials.gov registry record · NA

Social Media and Cancer Screening Information

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
2,030
Enrollment target

NCT06712901 is a NA study that has completed, run by University of Utah. The registered enrollment target is 2,030 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06712901, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
2,030 participants
Enrollment target

Study Summary

NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Median Ranked Cancer Screening Messaging
  • BEHAVIORAL Overall Preferred Cancer Screening Messaging
  • BEHAVIORAL Black American Preferred Cancer Screening Messaging
  • BEHAVIORAL White American Preferred Cancer Screening Messaging

Trial Details

FieldValue
Enrollment Target 2,030 participants
Start Date 2025-01-09
Est. Completion 2025-01-21
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT06712901

The ClinicalTrials.gov registry entry for NCT06712901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Control is the first listed.

NCT06712901 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06712901 about?

NCT06712901 is a clinical study titled "Social Media and Cancer Screening Information". NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messa...

What is the current status of trial NCT06712901?

This trial is currently completed. It is a NA study. The enrollment target is 2,030 participants. The study started on 2025-01-09. Estimated completion is 2025-01-21.

What interventions are being tested in trial NCT06712901?

The interventions under investigation include: Control (BEHAVIORAL), Median Ranked Cancer Screening Messaging (BEHAVIORAL), Overall Preferred Cancer Screening Messaging (BEHAVIORAL), Black American Preferred Cancer Screening Messaging (BEHAVIORAL), White American Preferred Cancer Screening Messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT06712901?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.